The SMART India Study conducted across multiple states and one union territory examined DR prevalence in over 6,000 people ...

ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.

GLP-1 receptor agonists were associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes.

Out of this, 4% have vision-threatening diabetic retinopathy (VTDR), which causes ... five years from the year of diagnosis and Type 2 patients should be screened when diagnosed.